Senior Manager, Market Access Marketing

The role

This person will translate clinical and economic evidence into value messaging and resources for AMTAGVI and pipeline therapies. They will lead the execution of U.S. market access strategy across payer and provider channels.

What you will do

• Support development and lead execution of U.S. market access strategy and annual tactical plans
• Support development of payer and provider value propositions
• Lead development and lifecycle management of payer and ATC resources
• Partner with cross-functional partners to identify evidence gaps and shape analyses
• Generate actionable payer and provider insights through market research and analytics
• Train and equip field teams with approved messaging and resources
• Manage agencies, vendors, budgets, timelines, and promotional review
• Translate payer, provider, reimbursement, policy, and competitive dynamics into recommendations
• Maintain standards of compliance, professional conduct, and ethical decision-making

Required qualifications

• Bachelor’s degree in life sciences, pharmacy, business, health economics, public health, economics, or a related field
• 7+ years with a bachelor’s degree, or 5+ years with an advanced degree, in pharmaceutical, biotechnology, healthcare, or managed markets
• 3+ years in U.S. market access marketing or strategy
• Experience developing payer- or provider-facing value propositions and materials
• Experience navigating medical, legal, and regulatory review
• Strong knowledge of the U.S. payer and provider landscape, medical-benefit reimbursement, utilization management, and health-system financial decision-making
• Ability to translate complex clinical and economic evidence into clear strategy and customer communications
• Proven cross-functional leadership, agency and project management, and ability to influence without direct authority
• Excellent written, verbal, presentation, analytical, and Microsoft Office skills

Nice to have

• Doctorate degree (PharmD, MD, DO or PhD)
• Cell therapy or hematology/oncology experience

About the company

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy company with U.S.-based manufacturing.